Table 3.
Ranked P-scores for primary and secondary outcomes.
| Endovascular intervention | Primary patency 12 mo | Technical success | Target lesion revascularization 12 mo | Rutherford improvement 12 mo | Major amputation 12 mo | All-cause death 12 mo | WIQ score change 12 mo | EQ-5D score change 12 mo |
|---|---|---|---|---|---|---|---|---|
| BMS+brachy | 0.75 | – | – | – | – | – | – | – |
| L+DCB | 0.74 | 0.47 | 0.27 | – | – | – | – | – |
| DCB+BMS | 0.73 | 0.34 | 0.74 | 0.99 | 0.2 | 0.59 | – | – |
| DES | 0.71 | 0.61 | 0.44 | 0.78 | 0.62 | 0.33 | – | – |
| CSG | 0.63 | 0.88 | 0.66 | 0.51 | – | 0.25 | – | – |
| A+DCB | 0.54 | 0.61 | 0.89 | 0.17 | – | 0.48 | – | 0.55 |
| PTA+A | 0.42 | 0.50 | 0.33 | – | – | 0.46 | – | – |
| BMS | 0.39 | 0.76 | 0.33 | 0.66 | 0.59 | 0.47 | – | – |
| DCB | 0.35 | 0.25 | 0.68 | 0.49 | 0.53 | 0.49 | 0.93 | 0.65 |
| Brachy | 0.24 | 0.19 | 0.46 | 0.2 | – | – | – | – |
| PTA | 0.01 | 0.12 | 0.05 | 0.2 | 0.55 | 0.46 | 0.06 | 0.29 |
| CBA | – | 0.74 | 0.63 | – | – | – | – | – |
Ranked P-scores for primary and secondary outcomes. P-scores indicate the certainty an intervention is superior than other interventions for the outcome.
A, atherectomy; BMS, bare metal stent; brachy, brachytherapy; CBA, cutting balloon angioplasty; CSG, covered stent graft; DCB, drug-coated balloon; DES, drug-eluting stent; EQ-5D, EuroQol 5-Dimension; L, lithotripsy; PTA, percutaneous transluminal angioplasty; WIQ, Walking Impairment Questionnaire.